Bobanga Iuliana D, McHenry Christopher R
Department of Surgery, University Hospitals Case Medical Center, Cleveland, OH, USA; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Case Western Reserve University School of Medicine, Cleveland, OH, USA; Department of Surgery, MetroHealth Medical Center, Cleveland, OH, USA.
Am J Surg. 2017 Mar;213(3):484-488. doi: 10.1016/j.amjsurg.2016.11.035. Epub 2016 Nov 23.
The purpose of this study was to determine if intraoperative parathyroid hormone (PTH) monitoring is necessary in patients with concordant ultrasound and sestamibi imaging.
Clinical factors, intraoperative findings and outcome were correlated with imaging results in patients with primary hyperparathyroidism who underwent parathyroidectomy with concordant ultrasound and sestamibi imaging.
There were 127 patients with primary hyperparathyroidism and concordant imaging who underwent parathyroidectomy. Seven patients (5.5%) had intraoperative findings that were discordant with imaging: 2 (1.6%) had an adenoma at a different location, 2 (1.6%) had double adenomas and 3 (2.4%) had asymmetric hyperplasia. Gland weight and preoperative PTH levels were greater for patients with concordant operative and imaging findings (p < 0.05).
Six percent of patients with concordant ultrasound and sestamibi imaging had unexpected intraoperative findings. Intraoperative PTH monitoring remains a necessary adjunct even with concordant imaging to ensure identification of abnormal parathyroid glands and cure of hyperparathyroidism.
本研究的目的是确定在超声和甲氧基异丁基异腈显像结果一致的患者中,术中甲状旁腺激素(PTH)监测是否必要。
对接受甲状旁腺切除术且超声和甲氧基异丁基异腈显像结果一致的原发性甲状旁腺功能亢进患者,将临床因素、术中发现及结果与显像结果进行关联分析。
127例原发性甲状旁腺功能亢进且显像结果一致的患者接受了甲状旁腺切除术。7例患者(5.5%)术中发现与显像结果不一致:2例(1.6%)在不同位置有腺瘤,2例(1.6%)有双腺瘤,3例(2.4%)有不对称增生。手术和显像结果一致的患者腺体重量和术前PTH水平更高(p<0.05)。
6%超声和甲氧基异丁基异腈显像结果一致的患者术中出现意外发现。即使显像结果一致,术中PTH监测仍是确保识别异常甲状旁腺并治愈甲状旁腺功能亢进的必要辅助手段。